Skip to content

A study of neurological damage in patients recovering from novel coronavirus pneumonia (COVID-19)

A study of neurological damage in patients recovering from novel coronavirus pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038471
Enrollment
Unknown
Registered
2020-09-23
Start date
2020-09-25
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Persons recovered from COVID-19 versus Health people:Nil

Sponsors

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All COVID-19 patients had previously been diagnosed with COVID-19 in the Infectious Disease Hospital of the First Affiliated Hospital of University of Science and Technology of China, and then were cured and discharged. The diagnostic and discharge criteria met the relevant standards set in the Novel Coronavirus Pneumonia Diagnosis and Treatment Plan promulgated by the National Health Commission at that time.After discharge, all patients were quarantined according to the Health Management Plan for CoVID-19 Discharged Patients (Trial) issued by the National Health Commission, and checked in designated hospitals 2 and 4 weeks after discharge; 2. The nucleic acid test of SARS-COV-2 was negative twice, and there were no respiratory symptoms such as fever, cough and sputum.Before enrollment, a pharyngeal swab nucleic acid test with SARS-CoV-2 was performed again, and only those with negative results could be enrolled; 3. The control group consists of healthy physical examiners matched to COVID-19 group in age, sex, and underlying disease.

Exclusion criteria

Exclusion criteria: Participants have contraindications to MRI.

Design outcomes

Primary

MeasureTime frame
Degree of leukoencephalopathy;Markers of vascular endothelial injury;

Countries

China

Contacts

Public ContactXiaoling Ding and Wei Xiong

The First Affiliated Hospital of University of Science and Technology of China

merryding@163.com+86 551-62283257/+86 551-63600057

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026